Saturday, April 11, 2009
Aurobindo Pharma enlarged prostate tablets
Aurobindo Pharma, a developer of generic pharmaceuticals and active pharmaceutical ingredients, has received its first product approval from Swissmedic, Government of Switzerland for the license of finasteride APL tablets (5mg). The drug is a generic equivalent of MERCK & CO Inc's Proscar Tablet.
Finasteride APL Tablet 5mg is used alone or in combination with another medication to treat benign prostatic hypertrophy (BPH, enlargement of the prostate gland). The drug is seen very effective in symptoms of BPH such as frequent and difficult urination. In addition, it also may decrease the chance of needing prostate surgery.
Further, the drug is also used to treat male pattern hair loss (a common condition in which men have gradual thinning of the hair on the scalp, leading to a receding hairline or balding on the top of the head.)
Finasteride APL Tablet 5mg is used alone or in combination with another medication to treat benign prostatic hypertrophy (BPH, enlargement of the prostate gland). The drug is seen very effective in symptoms of BPH such as frequent and difficult urination. In addition, it also may decrease the chance of needing prostate surgery.
Further, the drug is also used to treat male pattern hair loss (a common condition in which men have gradual thinning of the hair on the scalp, leading to a receding hairline or balding on the top of the head.)
